IMP
Process View
regulation of synapse structural plasticity
Any process that modulates the frequency, rate or extent of synapse structural plasticity. Synapse structural plasticity is a type of cytoskeletal remodeling; this remodeling is induced by stimuli that can lead to long term potentiation and it can be activity-dependent or -independent. Examples of cytoskeletal changes include the formation of new spines and increase in spine size; this can be accompanied by the insertion of greater numbers of glutamate (or other neurotransmitter) receptors into the post-synaptic membrane.
In addition to gene-name show these genes:
Click on a gene's description to view its network relationships with genes known to be involved in "regulation of synapse structural plasticity"
| Name | Description | Probability | Func Analog Organism | |
|---|---|---|---|---|
| RAC1 | ras-related C3 botulinum toxin substrate 1 (rho family, small GTP binding protein Rac1) | 0.271 | ||
| ADORA2A | adenosine A2a receptor | 0.221 | ||
| CYFIP2 | cytoplasmic FMR1 interacting protein 2 | 0.097 | ||
| GAB1 | GRB2-associated binding protein 1 | 0.069 | ||
| CMIP | c-Maf-inducing protein | 0.067 | ||
| AP1M1 | adaptor-related protein complex 1, mu 1 subunit | 0.067 | ||
| CYFIP1 | cytoplasmic FMR1 interacting protein 1 | 0.060 | ||
| PPP1R9B | protein phosphatase 1, regulatory (inhibitor) subunit 9B | 0.060 | ||
| ATN1 | atrophin 1 | 0.041 | ||
| WIPF1 | WAS/WASL interacting protein family, member 1 | 0.038 | ||
| DVL3 | dishevelled, dsh homolog 3 (Drosophila) | 0.037 | ||
| LDOC1 | leucine zipper, down-regulated in cancer 1 | 0.035 | ||
| PAK2 | p21 protein (Cdc42/Rac)-activated kinase 2 | 0.031 | ||
| HPS6 | Hermansky-Pudlak syndrome 6 | 0.031 | ||
| ALAS1 | aminolevulinate, delta-, synthase 1 | 0.029 | ||
| PIK3CA | phosphoinositide-3-kinase, catalytic, alpha polypeptide | 0.028 | ||
| TBK1 | TANK-binding kinase 1 | 0.026 | ||
| SLC6A3 | solute carrier family 6 (neurotransmitter transporter, dopamine), member 3 | 0.026 | ||
| LCMT1 | leucine carboxyl methyltransferase 1 | 0.024 | ||
| LTBP4 | latent transforming growth factor beta binding protein 4 | 0.019 | ||
| PAK3 | p21 protein (Cdc42/Rac)-activated kinase 3 | 0.019 | ||
| FAS | Fas (TNF receptor superfamily, member 6) | 0.018 | ||
| ARHGEF7 | Rho guanine nucleotide exchange factor (GEF) 7 | 0.018 | ||
| TSC22D4 | TSC22 domain family, member 4 | 0.017 | ||
| GKAP1 | G kinase anchoring protein 1 | 0.016 | ||
| KCTD4 | potassium channel tetramerisation domain containing 4 | 0.015 | ||
| ARL3 | ADP-ribosylation factor-like 3 | 0.014 | ||
| WASL | Wiskott-Aldrich syndrome-like | 0.013 | ||
| STK17A | serine/threonine kinase 17a | 0.013 | Human | |
| TDRD3 | tudor domain containing 3 | 0.013 | ||
| STAU1 | staufen, RNA binding protein, homolog 1 (Drosophila) | 0.012 | ||
| DMWD | dystrophia myotonica, WD repeat containing | 0.012 | ||
| RHOU | ras homolog gene family, member U | 0.011 | ||
| PAK4 | p21 protein (Cdc42/Rac)-activated kinase 4 | 0.011 | ||
| CACNB1 | calcium channel, voltage-dependent, beta 1 subunit | 0.011 | ||
| GAB2 | GRB2-associated binding protein 2 | 0.011 | ||
| PRKCZ | protein kinase C, zeta | 0.011 | ||
| TRIP6 | thyroid hormone receptor interactor 6 | 0.011 | ||
| KIT | v-kit Hardy-Zuckerman 4 feline sarcoma viral oncogene homolog | 0.011 | ||
| SNX9 | sorting nexin 9 | 0.011 | ||
| SLIT1 | slit homolog 1 (Drosophila) | 0.011 | ||
| KCNRG | potassium channel regulator | 0.010 | ||
| GIT1 | G protein-coupled receptor kinase interacting ArfGAP 1 | 0.010 | ||
| PIK3CG | phosphoinositide-3-kinase, catalytic, gamma polypeptide | 0.010 |